3361 research outputs found
Sort by
Consumer Willingness-To-Pay for a Resilient Electrical Grid
The research objective is to estimate consumer willingness to pay (WTP) for electricity grid fortification. Data are from a representative survey of Oklahoma citizens. Extreme weather events, aging utility infrastructure, increased demand for affordable energy, and terrorism threaten the safety and security of the way most citizens access electricity. This study is a first look at public willingness to support energy grid security measures in the United States Southern Great Plains. Findings suggest that consumers would pay an additional 14 initiated by local electricity providers. The findings provide policymakers and energy providers with information on consumer willingness to support efforts to modernize the current grid
Unlicensed to Work: An Analysis of the United States\u27 Human Rights Violation Against Asylum Seekers Due to the Unreasonable Waiting Period for Work Authorization, and How the Nation Forfeits an Economic Opportunity in the Process
Drug Dealing and the Internal Morality of Medicine
Which practices qualify as “medical” in nature? This question has important legal implications. Every state has laws prohibiting the “unauthorized practice of medicine.” Health insurance policies generally limit coverage to procedures that are “medically necessary.” And physicians can be prosecuted as drug traffickers if they prescribe controlled substances without a “legitimate medical purpose.” Each of these questions—and many others—hinge on how medicine is defined.
As with many common terms, we all have a general understanding of what medicine is and this heuristic suffices to carry us through our daily lives without complication. Yet when called on to produce a precise definition that captures all practices we think of as “medical,” while excluding those we do not, that task proves exceptionally challenging. This problem is further complicated by the fact that what qualifies as “medical” may vary across different contexts. Prescribing Botox to mitigate frown lines may qualify as a “medical” intervention for purposes of laws regulating doctors but may not qualify as “medically necessary” for purposes of insurance reimbursement.
Yet despite the difficulty of defining medicine and the weighty legal consequences that can hinge on these definitions, courts, regulators, and legal scholars have given little consideration to these challenges in the context of regulating physician prescribing. Instead, they have often relied on “commonsense” definitions that fail to grapple with the complexity of the issue. As a result, legal standards that govern prescribing are often unclear and inconsistently applied, leaving physicians without a clear understanding of which conduct they must avoid. Given multiple opportunities to resolve this issue definitively, the United States Supreme Court has repeatedly demurred, including most recently in its 2022 opinion in Ruan v. United States